Successful Reversal of Refractory Posttransplant Thrombotic Microangiopathy with Eculizumab.

Satish Chaudhary, Reetesh Sharma, Saumya Gupta, Sita Paikra,Mohit Gupta, Bal K Upadhyay,Alok Sharma, Rajiv K Sethia

Indian journal of nephrology（2023）

引用 0|浏览0

暂无评分

摘要

Posttransplant thrombotic microangiopathy (PT-TMA) can be caused by calcineurin inhibitors (CNIs), ischemic injury, infections, or antibody-mediated rejection (ABMR). Delayed recognition can result in allograft loss. We describe the first reported case of successful reversal of refractory PT-TMA with eculizumab in India. It highlights the importance of prompt diagnosis and benefit from an early initiation of eculizumab therapy in refractory cases.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要